Report : Middle East & Africa Patient Simulators Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Adult Patient Simulator, Infant Simulator, and Childbirth Simulator) and End User (Academic Institutes, Hospitals, and Military Organizations)
At 14.5% CAGR, the Middle East & Africa Patient Simulators Market is speculated to be worth US$ 215.49 million by 2028, says Business Market Insights
According to Business Market Insights’ research, the Middle East & Africa patient simulators market was valued at US$ 95.47 million in 2022 and is expected to reach US$ 215.49 million by 2028, registering a CAGR of 14.5% from 2022 to 2028. Growing technological advancements in patient simulators and increase in demand for minimally invasive treatment methods are the critical factors attributed to the Middle East & Africa patient simulators market expansion.
A minimally invasive medical procedure is generally performed by entering the device in the body through the skin, a body cavity, or an anatomical opening, but with the least damage possible to these structures. In recent years, significant improvement has been made in cardiovascular disease treatment. However, these complex medical procedures require rich experience and technical expertise. The complex treatment of cardiovascular diseases is made more comfortable with the help of simulators. The system can produce realistic 3D vascular models segmented from patient datasets, which include a beating heart, and give a real-time computation of force and force feedback module for patient simulators. Robotic surgery and patient simulators both use a mechanized interface that provides visual patient reactions in response to the actions of the health care professional, monitors to visualize the change of the procedure, and computer software applications through which the health care professional interacts. Both technologies are undergoing rapid adoption and are viewed as modalities that allow physicians to perform increasingly complex minimally invasive procedures while enhancing patient safety. Advanced minimally invasive surgery (MIS), which is robot-assisted surgery, is becoming increasingly accepted. There is a growing need for training residents in this type of surgery. The increasing demand for MIS is boosting the growth of the Middle East & Africa patient simulators market.
On the contrary, high cost of patient simulators hurdles the growth of Middle East & Africa patient simulators market.
Based on product, the Middle East & Africa patient simulators market is segmented into adult patient simulator, infant simulator, and childbirth simulator. The adult patient simulator segment held 48.7% share of Middle East & Africa patient simulators market in 2022, amassing US$ 46.50 million. It is projected to garner US$ 107.50 million by 2028 to expand at 15.0% CAGR during 2022–2028.
Based on end user, the Middle East & Africa patient simulators market is segmented into academic institutes, hospitals, and military organizations. The academic institutes segment held 55.7% share of Middle East & Africa patient simulators market in 2022, amassing US$ 53.19 million. It is projected to garner US$ 122.82 million by 2028 to expand at 15.0% CAGR during 2022–2028.
Based on country, the Middle East & Africa patient simulators market has been categorized into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Our regional analysis states that South Africa captured 40.9% share of Middle East & Africa patient simulators market in 2022. It was assessed at US$ 39.01 million in 2022 and is likely to hit US$ 88.90 million by 2028, exhibiting a CAGR of 14.7% during the forecast period.
Key players dominating the Middle East & Africa patient simulators market are CAE Inc, Gaumard Scientific Co Inc, Kyoto Kagaku Co Ltd, Laerdal Medical AS, Limbs & Things Ltd, Mentice AB, Simulab Corp, Surgical Science Sweden AB, and VirtaMed AG among others.
- In Oct 2020, Mentice AB signed a definitive agreement to acquire Vascular Simulations (VSI). The acquisition expanded Mentice's global leadership role within endovascular simulation by offering value solutions that support all stages of a medical device's development cycle.
- In April 2022, CAE Healthcare started deliveries of its newest high-fidelity paediatric patient simulator, CAE Aria. The Company ramped up production to accommodate demand for the medical manikin amid increasing challenges accessing paediatric patients for clinical training.
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email id: email@example.com